Rigshospitalet Copenhagen

Rigshospitalet Copenhagen is now our clinical partner

News  Rigshospitalet Copenhagen is now our clinical partner The study is designed as follows: Pilot study Inclusion of 10-15 healthy children and children with known visual field defects (ages 4-12) to test the setup of the equipm ent and the possibility of detection of visual field defect. The children will also go through some basic […]

Bulbitech qualified for the semifinal of EIT Health Catapult 2022-23

News  Bulbitech qualified for the semifinal of of EIT Health Catapult 2022-23 Bulbitech qualified for the semifinal of EIT Health Catapult 2022-23. This competition showcases the most promising European startups in three categories – biotech, medtech, and digital health. There are 42 companies in total and Bulbitech is selected as one of 14 most promising […]

Bulbitech AS is proud to announce Dr. Oleg Komogortsev is joining Bulbitech’s advisory board.

News  Bulbitech AS is proud to announce Dr. Oleg Komogortsev is joining Bulbitech’s advisory board. After an initial meeting at NANOS 2022 and several follow-up meetings both parties became convinced that his role as an advisor with regards to topics as Artificial Intelligence, Eye Tracking signal capture and its interpretationin relation to biometric data and human computer […]

Bulbitech is amongst the Top 20 Nordic Impact-Driven AI companies & Start-ups 2022

News  Bulbitech is amongst the Top 20 Nordic Impact-Driven AI companies & Start-ups 2022 Bulbitech is amongst the Top 20 Nordic Impact-Driven AI companies & Start-ups 2022, according to Omdena, a collaborative platform where the global community of AI engineers collaboratively builds real-world solutions. Thank you for your recognition. Share on facebook Facebook Share on […]

Bulbitech AS is proud to announce Michael Strupp, statutory Professor of Neurology and Clinical Neurophysiology, is joining Bulbitech’s clinical advisory board.

Bulbitech AS is proud to announce Michael Strupp, statutory Professor of Neurology and Clinical Neurophysiology, is joining Bulbitech’s clinical advisory board. Bulbitech AS is proud to announce Michael Strupp, MD, FRCP, FAAN, FEAN, FANA, statutory Professor of Neurology and Clinical Neurophysiology, is joining Bulbitech’s clinical advisory board. After an initial meeting, demo and several follow-up […]

Luka Opasic, MD, PhD has joined our team as Chief Data Officer.

News  Luka Opasic, MD, PhD has joined our team as Chief Data Officer. Bulbitech is pleased to announce that Luka Opasic, MD, PhD has joined our team as Chief Data Officer. “Since the precision of modern diagnostic tools relies heavily on the quality and quantity of data used for training of AI algorithms that power […]

Bulbitech_presentation

Bulbitech have entered into a strategic distribution agreement with Rodenstock Norge AS

Article / News  Bulbitech have entered into a strategic distribution agreement with Rodenstock Norge AS Trondheim, 25th of January 2022 Bulbitech is pleased to announce that we have entered into a strategic distribution agreement with Rodenstock Norge AS. Effective from January 1st, 2022, Rodenstock Norge AS is appointed as Bulbitech’s exclusive distributor for the Norwegian […]

University Vita Salute

University Vita Salute becomes clinical research partner of Bulbitech AS

Article / News  University Vita Salute becomes clinical research partner of Bulbitech AS Bulbitech is pleased to announce that we have entered into a clinical research agreement with University Vita Salute – Ospedale San Raffaele in Milan, Italy. Effective from January 14th, 2022, the University of Vita Salute will validate functional vision tests, performed with […]